|
No records
|
|
37085331400 |
Ahmad Fuady |
dr. Ahmad Fuady, M.Sc. |
Departemen Ilmu Kedokteran Komunitas |
Pendidikan Dokter (S1) |
Perspective piece COVID-19 and tuberculosis-related catastrophic costs |
Fuady A., Houweling T.A.J., Richardus J.H. |
American Journal of Tropical Medicine and Hygiene |
1 |
Q1 |
|
|
|
37085506800 |
Muchtaruddin Mansyur |
Dr. dr. Muchtaruddin Mansyur, M.S., Sp.OK., Ph.D. |
Departemen Ilmu Kedokteran Komunitas |
Kedokteran Okupasi (Sp-1) |
Exploring HIV stigma among future healthcare providers in Indonesia |
Waluyo A., Mansyur M., Earnshaw V.A., Steffen A., Herawati T., Maria R., Culbert G.J. |
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV |
|
Q1 |
|
|
|
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis |
Lazarus G., Tjoa K., Iskandar A.W.B., Louisa M., Sagwa E.L., Padayatchi N., Soetikno V. |
PLoS ONE |
|
Q1 |
|
|
|
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA |
Sandhiutami N.M.D., Arozal W., Louisa M., Rahmat D., Wuyung P.E. |
Frontiers in Pharmacology |
|
Q1 |
|
|
|
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Tpmt genetic variability and its association with hematotoxicity in indonesian children with acute lymphoblastic leukemia in maintenance therapy |
Rosdiana D.S., Setiabudy R., Andalusia R., Gatot D., Louisa M., Bardosono S., Instiaty I. |
Pharmacogenomics and Personalized Medicine |
|
Q1 |
|
|
|
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Development, characterization and pharmacokinetic profile of chitosan-sodium tripolyphosphate nanoparticles based drug delivery systems for curcumin |
Arozal W., Louisa M., Rahmat D., Chendrana P., Sandhiutami N.M.D. |
Advanced Pharmaceutical Bulletin |
1 |
Q1 |
|
|
|
50162572300 |
Rini Sekartini |
Prof. Dr. dr. Rini Sekartini, SpA(K) |
Departemen Ilmu Kesehatan Anak |
Ilmu Kesehatan Anak (Sp-1) |
Internet addiction in adolescents: Development and validation of Internet Addiction Diagnostic Questionnaire (KDAI) |
Siste K., Wiguna T., Bardasono S., Sekartini R., Pandelaki J., Sarasvita R., Suwartono C., Murtani B.J., Damayanti R., Christian H., Sen L.T., Nasrun M.W. |
Psychiatry Research |
|
Q1 |
|
|
|
54886816200 |
Anis Karuniawati |
dr. Anis Karuniawati, SpMK., Ph.D |
Departemen Mikrobiologi |
Mikrobiologi (Sp-1) |
Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review |
Saharman Y.R., Karuniawati A., Severin J.A., Verbrugh H.A. |
Antimicrobial Resistance and Infection Control |
|
Q1 |
|
|
|
54886816200 |
Anis Karuniawati |
dr. Anis Karuniawati, SpMK., Ph.D |
Departemen Mikrobiologi |
Mikrobiologi (Sp-1) |
Erratum: Procalcitonin (PCT)guided antibiotic stewardship in Asia-Pacific countries: Adaptation based on an expert consensus meeting. (Clin Chem Lab Med (2020) 58:12 (1983–91) Doi:10.1515/cclm-2019-1122) |
Lee C.-C., Kwa A.L.H., Apisarnthanarak A., Feng J.-Y., Gluck E.H., Ito A., Karuniawati A., Periyasamy P., Pratumvinit B., Sharma J., Solante R., Swaminathan S., Tyagi N., Vu D.M., Zirpe K., Schuetz P. |
Clinical Chemistry and Laboratory Medicine |
|
Q1 |
|
|
|
54886816200 |
Anis Karuniawati |
dr. Anis Karuniawati, SpMK., Ph.D |
Departemen Mikrobiologi |
Mikrobiologi (Sp-1) |
Pneumococcal nasopharyngeal carriage in Indonesia infants and toddlers post-PCV13 vaccination in a 2+1 schedule: A prospective cohort study |
Prayitno A., Supriyatno B., Munasir Z., Karuniawati A., Hadinegoro S.R.S., Prihartono J., Safari D., Sundoro J., Khoeri M.M. |
PLoS ONE |
|
Q1 |
|
|
